Notice
- PR information Notice Regarding Alliance Between Alfresa Corporation, CMIC HOLDINGS Co., Ltd., and CMIC Trust Co., Ltd. for the Establishment of Comprehensive Vaccination Support Platforms
- PR information Notice Regarding Basic Business Alliance Agreement between Alfresa Corporation and K Pharma, Inc. Regarding the Supply Chain for iPS Cell-Derived Regenerative Medicine Products and Investment Agreement Regarding Bonds with Share Acquisition Rights Issued
- PR information Investment in SBI Investment Limited Partnership Venture Fund 2023 by Alfresa Corporation
- PR information Realization of Regular Drone-Based Deliveries of Pharmaceuticals in Accordance with Guidelines
- Others Notice regarding Alfresa Group Companies Recognized as the 2025 Outstanding Organizations of KENKO Investment for Health Program
- PR information Notice Regarding Achievement of ISO 9001 Certification by Alfresa Corporation Efforts to Improve Logistics Quality in the Alfresa Group
- PR information Notice Regarding Capital and Business Alliance Between Alfresa Corporation and Ascent Robotics Corporation
- PR information Notice Regarding the Establishment of the Pharmaceutical Sales Strategy Committee in Alfresa Corporation
- PR information Establishment of a New Company That Will Provide Online Healthcare Services for Health Management and the Prevention of Serious Illnesses for Employees of Road Haulage Operators
- PR information Notice Regarding Business and Capital Alliance Between Alfresa Corporation and Medley, Inc.